The role of prolactin/vasoinhibins in cardiovascular diseases

被引：3
作者：
Zhao, Hui [1 ,2 ,3 ]
Gong, Sugang [3 ]
Shi, Yongcong [4 ]
Luo, Cijun [3 ]
Qiu, Hongling [3 ]
He, Jing [3 ]
Sun, Yuanyuan [3 ]
Huang, Yuxia [3 ]
Wang, Shang [3 ]
Miao, Yuqing [1 ,2 ]
Wu, Wenhui [3 ]
机构：
[1] Univ Shanghai Sci & Technol, Sch Mat & Chem, Shanghai 200093, Peoples R China
[2] Univ Shanghai Sci & Technol, Inst Bismuth & Rhenium, Shanghai 200093, Peoples R China
[3] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Dept Cardiopulm Circulat, 507 Zhengmin Rd, Shanghai 200433, Peoples R China
[4] Dongchuan Dist Peoples Hosp, Resp Med, Kunming, Yunnan, Peoples R China
来源：
ANIMAL MODELS AND EXPERIMENTAL MEDICINE | 2023年 / 6卷 / 02期
基金：
上海市自然科学基金; 中国国家自然科学基金;
关键词：
cardiovascular diseases; endothelial cells; prolactin; vasoinhibins; SERUM PROLACTIN CONCENTRATIONS; ENDOTHELIAL-CELLS; PERIPARTUM CARDIOMYOPATHY; PRECLINICAL ATHEROSCLEROSIS; CATHEPSIN-D; 16K PRL; RISK; SECRETION; DYSFUNCTION; EXPRESSION;
D O I：
10.1002/ame2.12264
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Prolactin (PRL) is a polypeptide hormone that is mainly synthesized and secreted by the lactotroph cells of the pituitary. There are two main isoforms of PRL: 23-kDa PRL (named full-length PRL) and vasoinhibins (including 5.6-18 kDa fragments). Both act as circulating hormones and cytokines to stimulate or inhibit vascular formation at different stages and neovascularization, including endothelial cell proliferation and migration, protease production, and apoptosis. However, their effects on vascular function and cardiovascular diseases are different or even contrary. In addition to the structure, secretion regulation, and signal transduction of PRL/vasoinhibins, this review focuses on the pathological mechanism and clinical significance of PRL/vasoinhibins in cardiovascular diseases.
引用
收藏
页码：81 / 91
页数：11
相关论文
共 50 条
  • [1] Prolactin and Vasoinhibins: Endogenous Players in Diabetic Retinopathy
    Triebel, Jakob
    Macotela, Yazmin
    Martinez de la Escalera, Gonzalo
    Clapp, Carmen
    IUBMB LIFE, 2011, 63 (10) : 806 - 810
  • [2] Role of Prolactin and Vasoinhibins in the Regulation of Vascular Function in Mammary Gland
    Carmen Clapp
    Stéphanie Thebault
    Gonzalo Martínez de la Escalera
    Journal of Mammary Gland Biology and Neoplasia, 2008, 13 : 55 - 67
  • [3] Role of prolactin and vasoinhibins in the regulation of vascular function in mammary gland
    Clapp, Carmen
    Thebault, Stephanie
    Martinez de la Escalera, Gonzalo
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2008, 13 (01) : 55 - 67
  • [4] Regulation of Blood Vessels by Prolactin and Vasoinhibins
    Clapp, Carmen
    Thebault, Stephanie
    Macotela, Yazmin
    Moreno-Carranza, Bibiana
    Triebel, Jakob
    Martinez de la Escalera, Gonzalo
    RECENT ADVANCES IN PROLACTIN RESEARCH, 2015, 846 : 83 - 95
  • [5] PROTECTIVE ROLE OF α-LIPOIC ACID IN ATHEROSCLEROSIS AND CARDIOVASCULAR DISEASES
    Lacheta, Dominika
    Olejarz, Wioletta
    BIULETYN WYDZIALU FARMACEUTYCZNEGO WARSZAWSKIEGO UNIWERSYTETU MEDYCZNEGO, 2019, (08): : 43 - 50
  • [6] Emerging Role of MicroRNAs in Cardiovascular Diseases
    De Rosa, Salvatore
    Curcio, Antonio
    Indolfi, Ciro
    CIRCULATION JOURNAL, 2014, 78 (03) : 567 - 575
  • [7] New Insights into the Role of Ferroptosis in Cardiovascular Diseases
    Fratta Pasini, Anna Maria
    Stranieri, Chiara
    Busti, Fabiana
    Di Leo, Edoardo Giuseppe
    Girelli, Domenico
    Cominacini, Luciano
    CELLS, 2023, 12 (06)
  • [8] The Role of Stem Cells in the Treatment of Cardiovascular Diseases
    Bakinowska, Estera
    Kielbowski, Kajetan
    Boboryko, Dominika
    Bratborska, Aleksandra Wiktoria
    Olejnik-Wojciechowska, Joanna
    Rusinski, Marcin
    Pawlik, Andrzej
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [9] Cytokines and their role in cardiovascular diseases
    Haybar, Habib
    Bandar, Bita
    Torfi, Ekhlas
    Mohebbi, Alireza
    Saki, Najmaldin
    CYTOKINE, 2023, 169
  • [10] Role of resistin in cardiovascular diseases: Implications for prevention and treatment
    Rachwalik, Maciej
    Hurkacz, Magdalena
    Sienkiewicz-Oleszkiewicz, Beata
    Jasinski, Marek
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 30 (08): : 865 - 874
12345